Valiant Laboratories Ltd (VALIANTLAB) — shareholding pattern, promoter holding, financials and share price

At ₹62.22 a share on 10 Jul 2026, Valiant Laboratories Ltd (VALIANTLAB) was valued at a price-to-earnings ratio of -103.03x against an industry P/E of 36.41x and a price-to-book of 1.44x on a book value of ₹43.14 per share as of Mar 2025. Solomo computes return on equity of -1.4% and return on capital employed of 0.76% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.

P/E

-103.03x

Industry P/E

36.41x

P/B

1.44x

EPS (TTM)

₹-0.6

Book value / share

₹43.14

ROE

-1.4%

ROCE

0.76%

ROA

-0.82%

Debt / equity

0.52x

Dividend yield

0%

EBITDA margin

3.67%

52-week range

₹50 – ₹114.72

Ratios are computed from filed results and the last recorded price. Not investment advice.

In the year ended Mar 2026, Valiant Laboratories Ltd (VALIANTLAB) reported revenue of ₹237 crore, net profit of ₹-3 crore and earnings per share of ₹-0.6. That compares with revenue of ₹133 crore and net profit of ₹-2 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹91.98 crore and net profit ₹1.76 crore (consolidated).